Duchenne muscular dystrophy is a stem cell disease

Duchenne muscular dystrophy is a stem cell disease
A normal mouse muscle fiber (top left) is contrasted with a muscle fiber from a mouse model of Duchenne muscular dystrophy (bottom right). In normal mice, stem cells (pink) express dystrophin (green) and are able to easily generate new muscle fibers, but in the disease model, there is no dystrophin and the stem cells lose their sense of direction and have trouble generating new muscle fibers. Reproduced with permission of Will Wang. Credit: Will Wang

A new study from The Ottawa Hospital and the University of Ottawa is poised to completely change our understanding of Duchenne muscular dystrophy and pave the way for far more effective treatments.

The study, published in Nature Medicine on November 16, 2015, is the first to show that Duchenne muscular dystrophy directly affects .

"For nearly 20 years, we've thought that the muscle weakness observed in patients with Duchenne muscular dystrophy is primarily due to problems in their muscle fibres, but our research shows that it is also due to intrinsic defects in the function of their muscle ," said Dr. Michael Rudnicki, senior author of the study. "This completely changes our understanding of Duchenne muscular dystrophy and could eventually lead to far more effective treatments."

Dr. Rudnicki is the Director of the Regenerative Medicine Program at The Ottawa Hospital and a professor at the University of Ottawa. He also holds the Canada Research Chair in Molecular Genetics.

Duchenne muscular dystrophy is the most common form of muscular dystrophy, affecting approximately one in 3,600 boys. It is caused by genetic mutations that result in the loss of the , leading to progressive and death by the second or third decade of life.

Muscle stem cells are responsible for after normal injuries and exercise. In response to , these stem cells divide to generate precursor cells that become the fibres that make up our muscles.

For many years, dystrophin was thought to be a simple structural protein only found in muscle fibres. In the current study, Dr. Rudnicki and his team discovered that muscle stem cells also express the dystrophin protein, and without this protein, they produce ten-fold fewer , which in-turn generate fewer functional muscle fibres. They also discovered that dystrophin is a key member of the molecular machinery that enables muscle stem cells sense their orientation in the surrounding tissue.

"Muscle stem cells that lack dystrophin cannot tell which way is up and which way is down," said Dr. Rudnicki. "This is crucial because muscle stem cells need to sense their environment to decide whether to produce more stem cells or to form new muscle fibres. Without this information, muscle stem cells cannot divide properly and cannot properly repair damaged muscle."

This research was conducted in mouse cells, but it is expected that the findings will hold in humans, as the dystrophin protein is almost identical in all animals.

Current treatments for Duchenne muscular dystrophy are limited to steroids and physical therapy that slow disease progression and lessen symptoms. Experimental approaches such as gene therapy are also being investigated, but Dr. Rudnicki's research suggests that these approaches will have to be modified so that they target muscle stem cells as well as .

"We're already looking at approaches to correct this problem in muscle stem cells," said Dr. Rudnicki. "I'm not sure if we will ever cure Duchenne muscular dystrophy, but I'm very hopeful that someday in the future, we will have new therapies that correct the ability of muscle stem cells to repair the muscles of afflicted patients and turn this devastating, lethal disease into a chronic but manageable condition."

The discovery is being hailed by experts in the field, including Dr. Ronald Worton, who co-discovered the gene for Duchenne muscular dystrophy in 1987 and served as Vice-President of research at The Ottawa Hospital for 11 years.

"When we discovered the gene for Duchenne , there was great hope that we would be able to develop a new treatment fairly quickly," said Dr. Worton, who is now retired. "This has been much more difficult than we initially thought, but Dr. Rudnicki's research is a major breakthrough that should renew hope for researchers, patients and families."

More information: Dystrophin expression in muscle stem cells regulates their polarity and asymmetric division, Nature Medicine, DOI: 10.1038/nm.3990

Journal information: Nature Medicine

Citation: Duchenne muscular dystrophy is a stem cell disease (2015, November 16) retrieved 7 June 2023 from https://medicalxpress.com/news/2015-11-duchenne-muscular-dystrophy-stem-cell.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Protein injection points to muscular dystrophy treatment


Feedback to editors